NSCLC (Advanced Non-small Cell Lung Cancer)
1 competing product in clinical development for NSCLC (Advanced Non-small Cell Lung Cancer).
Pipeline by Phase
Phase 1/21
All Products (1)
| Product | Company | Stage | Status | Hype |
|---|---|---|---|---|
| U3-1287 + Erlotinib + Placebo | Daiichi Sankyo | Phase 1/2 | Completed | 32 |